<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02786173</url>
  </required_header>
  <id_info>
    <org_study_id>PRIME</org_study_id>
    <nct_id>NCT02786173</nct_id>
  </id_info>
  <brief_title>Peripheral Registry of Endovascular Clinical Outcomes &quot;The PRIME Registry&quot;</brief_title>
  <acronym>PRIME</acronym>
  <official_title>Peripheral Registry of Endovascular Clinical Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Metro Health, Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>C. R. Bard</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cardiovascular Systems Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Metro Health, Michigan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The PRIME Registry is a multi-center, observational study designed to evaluate immediate and
      long-term outcomes (36 months) of endovascular revascularization in patients with critical
      limb ischemia (CLI) and advanced peripheral artery disease (PAD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Peripheral RegIstry of Endovascular Clinical OutcoMEs (PRIME Registry) represents the
      collaborative effort among seven centers across the US with the goal of reaching 10 sites
      globally. PRIME explores all aspects of advanced peripheral arterial disease (PAD) and
      critical limb ischemia (CLI) care including the collection of comprehensive clinical,
      diagnostic, procedural, and follow-up data for three years following an index endovascular
      procedure. Data collection activities began in January of 2013 with the goal of collecting
      data on 1500 subjects. Analysis of this multi-site registry will produce generalizable
      findings that describe the clinical epidemiology and management practices of advanced PAD and
      CLI patients.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 2013</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Amputation free survival rates</measure>
    <time_frame>At 36 month follow-up visit</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Access site and procedural complications</measure>
    <time_frame>At 36 month follow-up visit</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion revascularization</measure>
    <time_frame>At 36 month follow-up visit</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target vessel revascularization</measure>
    <time_frame>At 36 month follow-up visit</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural success</measure>
    <time_frame>At 36 month follow-up visit</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">1000</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <condition>Peripheral Vascular Disease</condition>
  <condition>Critical Limb Ischemia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who are to receive or have received lower extremity endovascular treatment for
        peripheral artery disease.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who are to receive or have received lower extremity endovascular intervention

          -  Rutherford III-VI Classification

          -  Ability to provide informed consent within 30 day prior to 60 days post index
             endovascular intervention.

          -  Ability to follow up at enrollment site.

        Exclusion Criteria:

          -  Inability or unwillingness to consent for participation in the registry.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jihad A Mustapha, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Physician</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Orlando Health</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prairie Heart</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Metro Health Hospital</name>
      <address>
        <city>Wyoming</city>
        <state>Michigan</state>
        <zip>49519</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cox Health</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65807</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rex Healthcare</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Hospitals of Providence</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79902</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>May 17, 2016</study_first_submitted>
  <study_first_submitted_qc>May 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 30, 2016</study_first_posted>
  <last_update_submitted>August 26, 2019</last_update_submitted>
  <last_update_submitted_qc>August 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PRIME</keyword>
  <keyword>PAD</keyword>
  <keyword>PVD</keyword>
  <keyword>Observational</keyword>
  <keyword>CLI</keyword>
  <keyword>PRIME Registry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

